title: [Point of note in the treatment of osteoporotic patients complicated with chronic kidney disease].
abstract: Chronic kidney disease causes secondary hyperparathyroidism due to an accumulation of phosphate in the circulation, resulting in the development of CKD-mineral bone disease(MBD), which increases the risk of cardiovascular disease and fracture. Increase of bone fracture in CKD might be explained by phosphate overload, increased oxidative stress, malnutrition, and the increased risk of fall due to sarcopenia. It is recently emphasized that the overtreatment of osteoporosis might induce the development of adynamic bone disease by calcium overload and/or oversuppression of bone turnover, which might stimulate ectopic calcification including vessel wall. Considering for the high prevalence of CKD in elderly osteoporotic women, we should be careful to avoid the induction of calcium/phosphate overload and over-suppression of bone turnover when we treat osteoporosis for such patients.
authors: Department of Metabolism, Endocrinology, and Molecular Medicine Osaka City University graduate School of Medicine, Japan.
authors: Masaaki
authors: M
authors: Inaba
mesh_terms: D015415:Biomarkers / Q000097:blood; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000378:metabolism; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D012307:Risk Factors; D061205:Vascular Calcification / Q000209:etiology
chemical_list: D015415:Biomarkers